Cargando…
Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers
SIMPLE SUMMARY: Germline BRCA1 and BRCA2 pathogenic variant carriers are recognized to be at increased risk for multiple cancers including breast, ovarian, pancreatic, and prostate cancer, with risk management recommendations for these cancers included in BRCA1/2 guidelines. Currently, it is remains...
Autores principales: | Buckley, Kole H., Niccum, Blake A., Maxwell, Kara N., Katona, Bryson W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736932/ https://www.ncbi.nlm.nih.gov/pubmed/36497436 http://dx.doi.org/10.3390/cancers14235953 |
Ejemplares similares
-
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017) -
Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007) -
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012) -
Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008) -
Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)